Due to health issues, this site is no longer maintained and will be shut down shortly.

SPRO Spero Therapeutics

SmartPros Ltd is engaged in providing learning & training solutions for accounting/finance, legal, insurance, banking, brokerage and engineering professionals in the United States. It also develops and hosts Websites, and produces custom videos.

$1.43  +0.06 (4.38%)
As of 03/24/2023 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2013
Outstanding shares:  35,067,477
Average volume:  475,487
Market cap:   $48,042,443
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BF4HN80
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy